Cargando…
Severe Systemic Rash in the Treatment of Hairy Cell Leukemia with Cladribine: Case Report and Literature Review
A 49-year-old male patient who had been diagnosed with variable hairy cell leukemia (HCL-V) was treated with interferon for half a year but exert no obvious effect. After two courses of chemotherapy with cladribine, he achieved remission, and splenomegaly significantly improved (the length in cranio...
Autores principales: | Dong, Huijie, Shen, Yingying, Shen, Yiping, Wu, Dijiong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682778/ https://www.ncbi.nlm.nih.gov/pubmed/33239902 http://dx.doi.org/10.2147/IJGM.S281476 |
Ejemplares similares
-
Remarkable Response of Hairy Cell Leukemia Variant to Single-Agent Cladribine
por: Otieno, Steve B, et al.
Publicado: (2022) -
Treatment of Classic Hairy Cell Leukemia: Targeting Minimal Residual Disease beyond Cladribine
por: Bohn, Jan-Paul, et al.
Publicado: (2022) -
Complete recovery of pyoderma gangrenosum after successful treatment of underlying hairy cell leukemia with cladribine
por: Tombak, Anıl, et al.
Publicado: (2015) -
Efficacy and Safety of Cladribine: Subcutaneous versus Intravenous Administration in Hairy Cell Leukemia Patients
por: Khorshid, Ola, et al.
Publicado: (2015) -
Hairy Cell Leukemia Presenting with Isolated Skeletal Involvement Successfully Treated by Radiation Therapy and Cladribine: A Case Report and Review of the Literature
por: Yonal-Hindilerden, Ipek, et al.
Publicado: (2015)